User profiles for "author:Daniel R Gaya"
 | Professor Daniel R GayaConsultant Gastroenterologist, Glasgow Royal Infirmary, Glasgow, UK Verified email at ggc.scot.nhs.uk Cited by 7436 |
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
CA Lamb, NA Kennedy, T Raine, PA Hendy, PJ Smith… - Gut, 2019 - gut.bmj.com
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …
Both represent chronic inflammation of the gastrointestinal tract, which displays …
New genes in inflammatory bowel disease: lessons for complex diseases?
The chronic inflammatory bowel diseases Crohn's disease and ulcerative colitis are
common causes of gastrointestinal disease in northern Europe, affecting as many as one in …
common causes of gastrointestinal disease in northern Europe, affecting as many as one in …
[HTML][HTML] SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD …
SARS-CoV-2 has caused a global health crisis and mass vaccination programmes provide
the best opportunity for controlling transmission and protecting populations. Despite the …
the best opportunity for controlling transmission and protecting populations. Despite the …
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
Background Anti-TNF drugs are effective treatments for the management of Crohn's disease
but treatment failure is common. We aimed to identify clinical and pharmacokinetic factors …
but treatment failure is common. We aimed to identify clinical and pharmacokinetic factors …
[HTML][HTML] HLA-DQA1* 05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn's disease
Background & Aims Anti–tumor necrosis factor (anti-TNF) therapies are the most widely
used biologic drugs for treating immune-mediated diseases, but repeated administration can …
used biologic drugs for treating immune-mediated diseases, but repeated administration can …
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
The COVID-19 pandemic is putting unprecedented pressures on healthcare systems
globally. Early insights have been made possible by rapid sharing of data from China and …
globally. Early insights have been made possible by rapid sharing of data from China and …
[HTML][HTML] Treatment of active Crohn's disease with an ordinary food-based diet that replicates exclusive enteral nutrition
Background & Aims Exclusive enteral nutrition (EEN) is the only established dietary
treatment for Crohn's disease (CD), but its acceptability is limited. There is a need for novel …
treatment for Crohn's disease (CD), but its acceptability is limited. There is a need for novel …
HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants
Pancreatitis occurs in approximately 4% of patients treated with the thiopurines azathioprine
or mercaptopurine. Its development is unpredictable and almost always leads to drug …
or mercaptopurine. Its development is unpredictable and almost always leads to drug …
Multicentre comparison of the Glasgow Blatchford and Rockall scores in the prediction of clinical end‐points after upper gastrointestinal haemorrhage
AJ Stanley, HR Dalton, O Blatchford… - Alimentary …, 2011 - Wiley Online Library
Aliment Pharmacol Ther 2011; 34: 470–475 Summary Background The Glasgow Blatchford
Score (GBS) is increasingly being used to predict intervention and outcome following upper …
Score (GBS) is increasingly being used to predict intervention and outcome following upper …
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial
S Danese, S Vermeire, G d'Haens, J Panés… - The Lancet …, 2022 - thelancet.com
Background A treat-to-target strategy, in which strictly defined treatment targets facilitate
decision making in clinical practice, is advocated as an optimised management approach for …
decision making in clinical practice, is advocated as an optimised management approach for …